Zhang Haomiao, Wu Hanfeng, Lu Jianjie, Shao Wencheng, Yu Lili
Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Department of Neurosurgery, Shanghai Gamma Hospital, Shanghai, China.
Front Oncol. 2023 Oct 11;13:1273465. doi: 10.3389/fonc.2023.1273465. eCollection 2023.
Orbital meningioma is a rare type of orbital tumor with high invasiveness and recurrence rates, making it extremely challenging to treat. Due to the special location of the disease, surgery often cannot completely remove the tumor, requiring postoperative radiation therapy. Here, we report a case of an elderly male patient with right-sided proptosis, visual impairment, and diplopia. Imaging diagnosis revealed a space-occupying lesion in the extraconal space of the right orbit. Pathological and immunohistochemical examination of the resected tumor confirmed it as a grade 3 anaplastic meningioma. Two months after surgery, the patient complained of right eye swelling and a magnetic resonance imaging (MRI) scan showed a recurrence of the tumor. The patient received helical tomotherapy (TOMO) in the postoperative tumor bed and high-risk areas within the orbit with a total dose of 48Gy. However, there was no significant improvement in the patient's right eye swelling, and the size of the recurrent lesion showed no significant change on imaging. Gamma knife multifractionated stereotactic radiosurgery (MF-SRS) was then given to the recurrent lesion with 50% prescription dose 13.5Gy/3f, once every other day. An imaging diagnosis performed 45 days later showed that the tumor had disappeared completely. The patient's vision remained unchanged, but diplopia was significantly relieved after MF-SRS. We propose a new hybrid treatment model for recurrent orbital meningioma, where conventional radiation therapy ensures local control of high-risk areas around the postoperative cavity, and MF-SRS maximizes the radiation dose to recurrent lesion areas while protecting surrounding tissues and organs.
眼眶脑膜瘤是一种罕见的眼眶肿瘤,具有高侵袭性和复发率,治疗极具挑战性。由于该疾病的特殊位置,手术往往无法完全切除肿瘤,术后需要进行放射治疗。在此,我们报告一例老年男性患者,有右侧眼球突出、视力障碍和复视症状。影像学诊断显示右侧眼眶锥外间隙有占位性病变。对切除肿瘤进行病理及免疫组化检查确诊为3级间变性脑膜瘤。术后两个月,患者诉右眼肿胀,磁共振成像(MRI)扫描显示肿瘤复发。患者在术后肿瘤床及眼眶内高危区域接受螺旋断层放疗(TOMO),总剂量为48Gy。然而,患者右眼肿胀无明显改善,影像学上复发灶大小无明显变化。随后对复发灶给予伽玛刀分次立体定向放射外科治疗(MF-SRS),处方剂量50%为13.5Gy/3次,隔日一次。45天后的影像学诊断显示肿瘤已完全消失。患者视力无变化,但MF-SRS后复视明显缓解。我们提出一种针对复发性眼眶脑膜瘤的新的综合治疗模式,即传统放疗确保对术后腔隙周围高危区域的局部控制,而MF-SRS在保护周围组织和器官的同时,将放射剂量最大化至复发灶区域。